Author: James Love
European generic drug companies ask EU Parliament to remove patents from ACTA
The European Generics Association has written to the European Parliament asking that patents be removed from the Anti-Counterfeiting Agreement. A PDF copy of their letter is here. The text in html follows:
MEP Mr. Gianluca Susta
INTA Committee
European Parliament
1049 Bruxelles- BelgiumBrussels, 5th of November 2010
Ref. EGA comments to the consolidated text on ACTA that reflects changes made during the
September 2010 Tokyo round1.
Dear Mr. Susta,
The 2010 US elections
This was originally published in the Huffington Post here.
————
Continue ReadingUSTR positions in China WTO TRIPS dispute at odds with talking points on ACTA flexibility
Use of Article 1.1 of the TRIPS in the US/China WTO dispute over the enforcement of intellectual property rights
USTR claims that Article 1.2.1 of ACTA provides the flexibility to overlook inconsistencies between US law and ACTA. Below is the text from both Article 1.2.1 of ACTA, and Article 1.1 of TRIPS:
Michèle Rivasi asks question about ACTA and Access to Medicine
Michèle Rivasi, a Member of the European Parliament, representing South East France for The Greens, has asked the European Commission: “Given the possible impacts of the inclusion of patents the agreement on access to medicines and on innovation, would the Commission consider accepting the exclusion of patents from the agreement as proposed by a number of ACTA negotiating parties?” The full text of her question follows:
Françoise Castex, French Socialist MEP, asks about USTR assertions that ACTA does not require changes in US law
As David Hammerstein of TACD has also blogged about here, Françoise Castex, a French Socialist MEP, has submitted this priority question about ACTA to the European Commission, asking the Commission to respond to the assertions by the USTR that ACTA wo Continue Reading
KEI Letter to the European Parliament regarding ACTA, October 25, 2010
(A PDF version of this is available here.)
Knowledge Ecology International
October 25, 2010
Letter to the European Parliament regarding ACTA
USTR’s implausible claim that ACTA Article 1.2 is an all purpose loophole, and the ramifications if true
The October 2010 version of the ACTA text is inconsistent with several areas of U.S. law, and proposals for new laws in the areas of the reform of patent damages and access to orphaned copyrighted works. In particular, the obligations in the ACTA text do not incorporate many of the areas of limitations and exceptions to remedies found in U.S. law, and in the statutes of some other countries.
Statement of the Holy See at 48th WIPO General Assembly
48th Series of Meetings of the World Intellectual Property Organization’s General Assemblies
Statement by H.E. Archbishop Silvano M. Tomasi, Permanent Representative of the Holy See to the United Nations and Other International Organizations in Geneva
at the 48th Series of Meetings of the World Intellectual Property Organization’s General Assemblies
Geneva, 21 September 2010
Mr. President,
Access to Orphan Works, and ACTA provisions on damages
Access to Orphan Works, and ACTA provisions on damages
KEI Policy Brief 2010: 1
20 October 2010Introduction
Copyright is a term that in the United States describes the laws that regulate the use and distribution of “original works of authorship.” The types of activities and expressions protected by copyright have expanded over the years, particularly due to technology, but also due to the lobbying by various interested parties. The current systems of registration of copyrighted works in the United includes the following catagories: